Journal of Neuro-Oncology

, 94:243

The role of Gamma Knife surgery in the treatment of skull base chordomas

  • Kasandra Dassoulas
  • David Schlesinger
  • Chun Po Yen
  • Jason Sheehan
Clinical Study - Patient Study

Abstract

Skull base chordomas are a rare neoplasm arising from the notochord. Although histologically benign, these tumors are locally aggressive and present significant management challenges. The current series describes the experience at the University of Virginia with Gamma Knife surgery (GKS) in the treatment of chordomas. Fifteen patients (8 males and 7 females) had undergone GKS between 1990 and 2007. The median age was 46 years (range 13–80). The most common presenting symptom was visual disturbance, found in 73%. Twelve patients had undergone tumor resection. Mean tumor volume at the time of GKS was 5.8 cm3 (range 1.03–15.6 cm3). Mean prescription dose was 12.7 Gy (range 12–20) and mean maximal dose was 36.7 Gy (range 28–50). Imaging follow-up was available for all patients with a median time of 88 months (range 8–167 months), and clinical follow-up was available for 11 patients with a median of 70 months (range 8–132). Three patients underwent a second Gamma Knife surgery to treat out of field progression. A Kaplan–Meier plot showed 5 and 10 year actuarial tumor control rates of 50.3% including those undergoing repeat GKS. Symptomatic progression was seen in 75% of the patients. No statistically significant predictive variables among margin dose, maximal dose, tumor volume, number of isocenters, age, and gender were found. GKS affords a reasonable rate of local tumor control in patients with recurrent or residual chordomas. However further long-term follow-up would be necessary to exclude the possibility of late recurrences.

Keywords

Chordoma Gamma Knife Radiosurgery Skull base 

References

  1. 1.
    McMaster ML, Goldstein AM, Bromley CM et al (2001) Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 12:1–11. doi:10.1023/A:1008947301735 PubMedCrossRefGoogle Scholar
  2. 2.
    Noel G, Habrand JL, Jauffret E et al (2003) Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Strahlenther Onkol 179:241–248. doi:10.1007/s00066-003-1065-5 PubMedCrossRefGoogle Scholar
  3. 3.
    Chugh R, Tawbi H, Lucas DR et al (2007) Chordoma: the nonsarcoma primary brain tumor. Oncologist 12:1344–1350. doi:10.1634/theoncologist.12-11-1344 PubMedCrossRefGoogle Scholar
  4. 4.
    Rich TA, Schiller A, Suit HD et al (1985) Clinical and pathologic review of 48 cases of chordoma. Cancer 56:182–187. doi:10.1002/1097-0142(19850701)56:1<182::AID-CNCR2820560131>3.0.CO;2-J PubMedCrossRefGoogle Scholar
  5. 5.
    Catton C, O’Sullivan B, Bell R et al (1996) Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 41:67–72PubMedGoogle Scholar
  6. 6.
    Fagundes MA, Hug EB, Liebsch NJ et al (1995) Radiation therapy for chordomas of the base of the skull and cervical spine: patterns of failure and outcome after relapse. Int J Radiat Oncol Biol Phys 33:579–584. doi:10.1016/0360-3016(95)02014-3 PubMedGoogle Scholar
  7. 7.
    Santoni R, Liebsch N, Finkelstein DM et al (1998) Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chodrosarcomas of the base of the skull. Int J Radiat Oncol Biol Phys 41:59–68. doi:10.1016/S0360-3016(98)00031-5 PubMedGoogle Scholar
  8. 8.
    Muthukumar N, Kondziolka D, Lunsford LD et al (1998) Stereotactic radiosurgery for chordoma and condrosarcoma: further experiences. Int J Radiat Oncol Biol Phys 41:387–392. doi:10.1016/S0360-3016(98)00051-0 PubMedGoogle Scholar
  9. 9.
    Martin JJ, Niranjan A, Kondziolka D et al (2007) Radiosurgery for chordomas and chondrosarcomas of the skull base. J Neurosurg 107:758–764. doi:10.3171/JNS-07/10/0758 PubMedCrossRefGoogle Scholar
  10. 10.
    Krishnan S, Foote RL, Brown PD et al (2005) Radiosurgery for cranial base chordomas and chondrosarcomas. Neurosurgery 56:777–784. doi:10.1227/01.NEU.0000156789.10394.F5 PubMedCrossRefGoogle Scholar
  11. 11.
    Pamir MN, Kilic T, Ture U et al (2004) Multimodality management of 26 skull-base chordomas with 4-year mean follow-up: experience at a single institution. Acta Neurochir (Wien) 146:343. doi:10.1007/s00701-004-0218-3 CrossRefGoogle Scholar
  12. 12.
    Hasegawa T, Ishii D, Kida Y et al (2007) Gamma Knife surgery for skull base chordomas and chondrosarcomas. J Neurosurg 107:752–757. doi:10.3171/JNS-07/10/0752 PubMedCrossRefGoogle Scholar
  13. 13.
    Feigl GC, Bundschuh O, Gharabaghi A et al (2005) Evaluation of a new concept for the management of skull base chordomas and chondrosarcomas. J Neurosurg 102(Suppl):165–170PubMedCrossRefGoogle Scholar
  14. 14.
    Colli BO, Al-Mefty O (2001) Chordomas of the skull base: follow-up review and prognostic factors. Neurosurg Focus 10:1–11. doi:10.3171/foc.2001.10.3.2 CrossRefGoogle Scholar
  15. 15.
    Samii A, Gerganov VM, Herold C et al (2007) Chordomas of the skull base: surgical management and outcome. J Neurosurg 107:319–324. doi:10.3171/JNS-07/08/0319 PubMedCrossRefGoogle Scholar
  16. 16.
    Samii M, Gerganov VM (2008) Surgery of extra-axial tumors of the cerebral base. Neurosurgery 62(Suppl 3):1153–1169PubMedGoogle Scholar
  17. 17.
    Sheehan JP, Niranjan A, Sheehan JM et al (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102:678–691PubMedCrossRefGoogle Scholar
  18. 18.
    Snell JW, Sheehan J, Stroila M et al (2006) Assessment of imaging studies used with radiosurgery: a volumetric algorithm and an estimation of its error. Technical note. J Neurosurg 104:157–162. doi:10.3171/jns.2006.104.1.157 PubMedCrossRefGoogle Scholar
  19. 19.
    Gay E, Sekhar L, Rubenstein E et al (1995) Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 36:887–897. doi:10.1097/00006123-199505000-00001 PubMedCrossRefGoogle Scholar
  20. 20.
    Tamaki N, Nagashima T, Ehara K et al (2001) Surgical approaches and strategies for skull base chordomas. Neurosurg Focus 10:1–7. doi:10.3171/foc.2001.10.3.10 CrossRefGoogle Scholar
  21. 21.
    Al-Mefty O, Borba LA (1997) Skull base chordomas: a management challenge. J Neurosurg 86:182–189PubMedCrossRefGoogle Scholar
  22. 22.
    Igaki H, Tokuuye K, Okumura T et al (2004) Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 60:1120–1126. doi:10.1016/j.ijrobp.2004.05.064 PubMedGoogle Scholar
  23. 23.
    Hug E, Loredo LN, Slater JD et al (1999) Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 91:432–439PubMedCrossRefGoogle Scholar
  24. 24.
    Cho YH, Kim JH, Khang KS et al (2008) Chordomas and chondrosarcomas of the skull base: comparative analysis of clinical results in 30 patients. Neurosurg Rev 31:35–43. doi:10.1007/s10143-007-0099-z PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  • Kasandra Dassoulas
    • 1
  • David Schlesinger
    • 1
  • Chun Po Yen
    • 1
  • Jason Sheehan
    • 1
  1. 1.Department of Neurological SurgeryUniversity of Virginia, Health Sciences CenterCharlottesvilleUSA

Personalised recommendations